Marked Sinus Bradycardia Associated With Remdesivir in COVID-19: A Case and Literature Review.

Autor:	Gubitosa JC; Department of Medicine, Rutgers New Jersey Medical School, Newark, New Jersey., Kakar P; Department of Cardiology, Rutgers New Jersey Medical School, Newark, New Jersey., Gerula C; Department of Cardiology, Rutgers New Jersey Medical School, Newark, New Jersey., Nossa H; Department of Infectious Disease, Rutgers New Jersey Medical School, Newark, New Jersey., Finkel D; Department of Infectious Disease, Rutgers New Jersey Medical School, Newark, New Jersey., Wong K; Department of Medicine-Pediatrics, Rutgers New Jersey Medical School, Newark, New Jersey., Khatri M; Department of Medicine-Pediatrics, Rutgers New Jersey Medical School, Newark, New Jersey., Ali H; Department of Medicine, Rutgers New Jersey Medical School, Newark, New Jersey.
Jazyk:	angličtina
Zdroj:	JACC. Case reports [JACC Case Rep] 2020 Nov 18; Vol. 2 (14), pp. 2260-2264. Date of Electronic Publication: 2020 Oct 28.
DOI:	10.1016/j.jaccas.2020.08.025
Abstrakt:	Remdesivir has seen extensive use during the coronavirus disease-2019 pandemic given its clinically proven efficacy against severe acute respiratory syndrome coronavirus type 2. There has been little cited regarding adverse effects. Here we present the case of a patient with marked sinus bradycardia that began acutely on initiation of remdesivir and resolved almost immediately on cessation of the drug. ( Level of Difficulty: Beginner. ). Competing Interests: The authors have reported that they have no relationships relevant to the contents of this paper to disclose. (© 2020 The Authors.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu